suggest that in cancer, doxorubicin‐triggered RhoA activation is associated with phospho‐cofilin dephosphorylation due to PDXP activation 48, and LPS was reported to dephosphorylate cofilin via PDXP induction 49. The gene discussed is PDXP; the disease is cancer.